Today's signals · MA aligned, MACD bullish cross
Signal details →Replimune Group last closed at $13.25 (+0.76%) on 2026-10-06. Signals today: MA aligned, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -4.3×. Its overall grade ranks 472 of 740 stocks in Healthcare.
About this company
Replimune Group last closed at $13.25 (+0.76%) on 2026-10-06. Signals today: MA aligned, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 472/740
Valuation grade B
Related stocks
- RocheCompetitor
종양면역·바이오암 치료제 개발 경쟁사
- AmgenCompetitor
암 치료 및 면역항암제 분야 경쟁사
- MerckCompetitor
면역항암제 시장의 핵심 경쟁사
ETFs holding this stock
Invesco DWA Healthcare Momentum ETF · Virtus LifeSci Biotech Clinical Trials ETF
Details →About Replimune Group
- What technical signals does Replimune Group (REPL) have?
- Replimune Group current technical signals: MA alignment (score 0.89).
- Is Replimune Group a cup-and-handle pattern?
- No. Replimune Group has no valid Cup signal right now.
- What published figures are available for Replimune Group?
- Market cap: $1.04B. Trailing 12 months PER: -4.3×. Latest quarter PBR: 12.15×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Replimune Group, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.